Masato Ishigami Selected Research

Masato Ishigami Research Topics

Disease

9	Atherosclerosis 12/2012 - 06/2003
9	Hyperlipidemias (Hyperlipidemia) 09/2012 - 05/2007
8	Coronary Artery Disease (Coronary Atherosclerosis) 01/2018 - 06/2007
6	Hypertriglyceridemia 01/2013 - 05/2007
5	Platelet Glycoprotein IV Deficiency 01/2012 - 05/2003
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2012 - 05/2007
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2012 - 10/2007
3	Insulin Resistance 12/2012 - 05/2003
3	Coronary Disease (Coronary Heart Disease) 09/2011 - 03/2005
3	Hyperlipoproteinemia Type III (Broad Beta Disease) 12/2009 - 06/2003
3	Tangier Disease 06/2009 - 08/2002
2	Dyslipidemias (Dyslipidemia) 01/2011 - 05/2009
2	Obesity 09/2010 - 03/2005
2	Hypertension (High Blood Pressure) 05/2009 - 05/2007
2	Takayasu Arteritis (Arteritis, Takayasu's) 09/2005 - 09/2003
1	Neoplasms (Cancer) 06/2022
1	Coronary Stenosis (Coronary Artery Stenosis) 09/2012
1	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 01/2012
1	Hyperthyroidism 01/2012
1	Hypothyroidism 01/2012
1	Inflammation (Inflammations) 01/2012
1	Thyroid Diseases (Thyroid Disease) 01/2012
1	Lipoprotein Glomerulopathy 01/2011
1	Rare Diseases (Rare Disease) 01/2011
1	Hyperlipoproteinemias 01/2010
1	Xanthomatosis (Xanthoma) 01/2010
1	Pancreatitis 01/2010
1	Hyperglycemia 05/2009
1	Hypoadiponectinemia 10/2007
1	Atherosclerotic Plaque (Atheroma) 07/2007
1	Abdominal Obesity 03/2005
1	Cholesteryl Ester Transfer Protein Deficiency 01/2003
1	Fatty Liver 02/2002
1	Alcoholic Fatty Liver 02/2002
1	Hepatocellular Carcinoma (Hepatoma) 02/2002

Drug/Important Bio-Agent (IBA)

11	Lipoproteins (Lipoprotein)IBA 12/2012 - 05/2003
9	HDL LipoproteinsIBA 01/2018 - 08/2002
6	Apolipoprotein B-48IBA 09/2012 - 01/2011
5	CholesterolIBA 12/2012 - 03/2005
5	Triglycerides (Triacylglycerol)IBA 01/2012 - 12/2007
4	oxidized low density lipoproteinIBA 12/2012 - 05/2007
4	ApolipoproteinsIBA 09/2012 - 02/2002
4	HDL CholesterolIBA 06/2010 - 07/2007
3	AdiponectinIBA 12/2012 - 07/2007
3	Apolipoprotein A-I (Apolipoprotein A1)IBA 10/2008 - 07/2007
2	Lipoprotein Lipase (Diacylglycerol Lipase)IBA 01/2013 - 01/2010
2	Glucose (Dextrose)FDA LinkGeneric 09/2012 - 05/2007
2	Biomarkers (Surrogate Marker)IBA 09/2012 - 07/2011
2	ChylomicronsIBA 09/2012 - 09/2011
2	Chylomicron RemnantsIBA 09/2012 - 05/2009
2	polyacrylamideIBA 01/2011 - 12/2009
1	Proteins (Proteins, Gene)FDA Link 06/2022
1	human ERBB2 proteinIBA 06/2022
1	Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA 06/2022
1	Glycosylphosphatidylinositols (Glycosyl-Phosphatidylinositol)IBA 01/2013
1	high density lipoprotein binding proteinIBA 01/2013
1	hydroxide ionIBA 01/2012
1	Hypolipidemic Agents (Antihyperlipidemics)IBA 01/2012
1	AntioxidantsIBA 01/2012
1	Probucol (Lorelco)FDA Link 01/2012
1	Thyroid HormonesIBA 01/2012
1	Thyroxine (Levothyroxine)FDA LinkGeneric 01/2012
1	CD36 AntigensIBA 01/2012
1	lipoprotein cholesterolIBA 07/2011
1	ORALIT (ORS)IBA 07/2011
1	Apolipoproteins E (ApoE)IBA 01/2011
1	Apolipoprotein E3IBA 01/2011
1	Ezetimibe (Zetia)FDA Link 09/2010
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 09/2010
1	Fenofibrate (CiL)FDA LinkGeneric 06/2010
1	Lipase (Acid Lipase)FDA Link 01/2010
1	BezafibrateIBA 01/2010
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 06/2009
1	Cholesterol Esters (Cholesteryl Esters)IBA 06/2009
1	PPAR gammaIBA 10/2008
1	IDL Lipoproteins (Lipoprotein, IDL)IBA 04/2008
1	LigandsIBA 05/2007
1	NF-kappa B (NF-kB)IBA 05/2007
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2007
1	Minocycline (Cyclops)FDA LinkGeneric 09/2005
1	Matrix Metalloproteinases (MMPs)IBA 09/2003
1	Atorvastatin (Lipitor)FDA Link 06/2003
1	Fatty Acids (Saturated Fatty Acids)IBA 05/2003
1	Cholesterol Ester Transfer ProteinsIBA 01/2003
1	Adenosine Triphosphate (ATP)IBA 08/2002
1	microsomal triglyceride transfer proteinIBA 02/2002
1	Ethanol (Ethyl Alcohol)IBA 02/2002

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 06/2022
1	Therapeutics 06/2022